Keywords: troglitazone, shows, promise, cancer, sankyo, facing, problems

Troglitazone shows promise in cancer

Article | 30 March 1999

Print This

Sankyo's troglitazone is facing problems in its primary indication oftype 2 diabetes (see page 20), but new research has suggested it may ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in